S&P 500   3,919.56 (-1.98%)
DOW   33,425.68 (-1.54%)
QQQ   281.03 (-2.30%)
AAPL   142.64 (-2.72%)
MSFT   244.75 (-2.18%)
META   114.24 (-6.69%)
GOOGL   96.86 (-2.63%)
AMZN   88.24 (-3.04%)
TSLA   178.25 (-2.30%)
NVDA   159.93 (-3.71%)
NIO   13.14 (+2.66%)
BABA   91.48 (+1.06%)
AMD   70.18 (-4.67%)
T   19.05 (+1.60%)
MU   53.43 (-1.13%)
CGC   3.58 (-17.13%)
F   13.11 (-2.02%)
GE   84.76 (+0.12%)
DIS   92.57 (-3.50%)
AMC   6.81 (-8.59%)
PYPL   71.67 (-2.65%)
PFE   49.90 (-1.64%)
NFLX   304.35 (-2.64%)
S&P 500   3,919.56 (-1.98%)
DOW   33,425.68 (-1.54%)
QQQ   281.03 (-2.30%)
AAPL   142.64 (-2.72%)
MSFT   244.75 (-2.18%)
META   114.24 (-6.69%)
GOOGL   96.86 (-2.63%)
AMZN   88.24 (-3.04%)
TSLA   178.25 (-2.30%)
NVDA   159.93 (-3.71%)
NIO   13.14 (+2.66%)
BABA   91.48 (+1.06%)
AMD   70.18 (-4.67%)
T   19.05 (+1.60%)
MU   53.43 (-1.13%)
CGC   3.58 (-17.13%)
F   13.11 (-2.02%)
GE   84.76 (+0.12%)
DIS   92.57 (-3.50%)
AMC   6.81 (-8.59%)
PYPL   71.67 (-2.65%)
PFE   49.90 (-1.64%)
NFLX   304.35 (-2.64%)
S&P 500   3,919.56 (-1.98%)
DOW   33,425.68 (-1.54%)
QQQ   281.03 (-2.30%)
AAPL   142.64 (-2.72%)
MSFT   244.75 (-2.18%)
META   114.24 (-6.69%)
GOOGL   96.86 (-2.63%)
AMZN   88.24 (-3.04%)
TSLA   178.25 (-2.30%)
NVDA   159.93 (-3.71%)
NIO   13.14 (+2.66%)
BABA   91.48 (+1.06%)
AMD   70.18 (-4.67%)
T   19.05 (+1.60%)
MU   53.43 (-1.13%)
CGC   3.58 (-17.13%)
F   13.11 (-2.02%)
GE   84.76 (+0.12%)
DIS   92.57 (-3.50%)
AMC   6.81 (-8.59%)
PYPL   71.67 (-2.65%)
PFE   49.90 (-1.64%)
NFLX   304.35 (-2.64%)
S&P 500   3,919.56 (-1.98%)
DOW   33,425.68 (-1.54%)
QQQ   281.03 (-2.30%)
AAPL   142.64 (-2.72%)
MSFT   244.75 (-2.18%)
META   114.24 (-6.69%)
GOOGL   96.86 (-2.63%)
AMZN   88.24 (-3.04%)
TSLA   178.25 (-2.30%)
NVDA   159.93 (-3.71%)
NIO   13.14 (+2.66%)
BABA   91.48 (+1.06%)
AMD   70.18 (-4.67%)
T   19.05 (+1.60%)
MU   53.43 (-1.13%)
CGC   3.58 (-17.13%)
F   13.11 (-2.02%)
GE   84.76 (+0.12%)
DIS   92.57 (-3.50%)
AMC   6.81 (-8.59%)
PYPL   71.67 (-2.65%)
PFE   49.90 (-1.64%)
NFLX   304.35 (-2.64%)
NASDAQ:SYNH

Syneos Health - SYNH Stock Forecast, Price & News

$33.73
-0.93 (-2.68%)
(As of 12/6/2022 02:21 PM ET)
Add
Compare
Today's Range
$33.37
$34.83
50-Day Range
$25.70
$51.45
52-Week Range
$22.89
$104.17
Volume
18,999 shs
Average Volume
1.75 million shs
Market Capitalization
$3.47 billion
P/E Ratio
12.27
Dividend Yield
N/A
Price Target
$56.90

Syneos Health MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
67.2% Upside
$56.90 Price Target
Short Interest
Healthy
2.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.00
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-18.08%
From $4.26 to $3.49 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Medical Sector

66th out of 1,023 stocks

Commercial Physical Research Industry

3rd out of 18 stocks

SYNH stock logo

About Syneos Health (NASDAQ:SYNH) Stock

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

Receive SYNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.

SYNH Stock News Headlines

Syneos Health Releases 2023 Health Trends
Is Investing in Syneos Health (SYNH) Risky?
Is it a Great Move to Invest in Syneos Health (SYNH)?
Why did Syneos Health stock surge today?
Syneos Health's Debt Overview
Syneos Health Reports Third Quarter 2022 Results
Earnings Outlook For Syneos Health
See More Headlines
Receive SYNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.

SYNH Company Calendar

Last Earnings
11/03/2021
Today
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/16/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SYNH
Employees
28,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$56.90
High Stock Price Forecast
$81.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+68.7%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
10 Analysts

Profitability

Net Income
$234.83 million
Pretax Margin
7.22%

Debt

Sales & Book Value

Annual Sales
$5.21 billion
Cash Flow
$6.08 per share
Book Value
$32.91 per share

Miscellaneous

Free Float
102,554,000
Market Cap
$3.47 billion
Optionable
Optionable
Beta
1.69

Key Executives

  • Ms. Michelle KeefeMs. Michelle Keefe (Age 55)
    CEO & Director
    Comp: $580.7k
  • Mr. Jason M. MeggsMr. Jason M. Meggs (Age 46)
    Chief Financial Officer
    Comp: $610.77k
  • Mr. Michael Lee BrooksMr. Michael Lee Brooks (Age 48)
    Chief Operating Officer
    Comp: $771.47k
  • Mr. Jonathan OlefsonMr. Jonathan Olefson (Age 46)
    Gen. Counsel & Corp. Sec.
    Comp: $511.49k
  • Mr. Alistair MacdonaldMr. Alistair Macdonald (Age 52)
    Advisor
    Comp: $1.25M
  • Ms. Donna Hildebrand KralowetzMs. Donna Hildebrand Kralowetz (Age 51)
    Sr. VP of Fin. & Chief Accounting Officer
  • Mr. Baba Shetty
    Pres of Technology & Data Solutions
  • Dr. Judith Ng-Cashin M.D. (Age 53)
    Chief Scientific Officer
  • Mr. Larry A. Pickett Jr.
    Chief Information & Digital Officer
  • Ronnie Speight
    Sr. VP of Investor Relations













SYNH Stock - Frequently Asked Questions

Should I buy or sell Syneos Health stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last twelve months. There are currently 6 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares.
View SYNH analyst ratings
or view top-rated stocks.

What is Syneos Health's stock price forecast for 2023?

10 equities research analysts have issued 12 month target prices for Syneos Health's shares. Their SYNH share price forecasts range from $30.00 to $81.00. On average, they expect the company's stock price to reach $56.90 in the next year. This suggests a possible upside of 64.2% from the stock's current price.
View analysts price targets for SYNH
or view top-rated stocks among Wall Street analysts.

How have SYNH shares performed in 2022?

Syneos Health's stock was trading at $102.68 on January 1st, 2022. Since then, SYNH shares have decreased by 66.2% and is now trading at $34.66.
View the best growth stocks for 2022 here
.

When is Syneos Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our SYNH earnings forecast
.

How were Syneos Health's earnings last quarter?

Syneos Health, Inc. (NASDAQ:SYNH) announced its earnings results on Wednesday, November, 3rd. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.05. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.34 billion. Syneos Health had a trailing twelve-month return on equity of 14.01% and a net margin of 5.31%. The company's revenue for the quarter was up 22.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.93 earnings per share.

What guidance has Syneos Health issued on next quarter's earnings?

Syneos Health updated its FY 2022 earnings guidance on Friday, November, 18th. The company provided earnings per share (EPS) guidance of $4.69-$4.87 for the period, compared to the consensus estimate of $4.98. The company issued revenue guidance of $5.30 billion-$5.36 billion, compared to the consensus revenue estimate of $5.47 billion.

What is Alistair Macdonald's approval rating as Syneos Health's CEO?

322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Who are Syneos Health's major shareholders?

Syneos Health's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (10.28%), Vanguard Group Inc. (9.57%), Massachusetts Financial Services Co. MA (3.38%), Cooke & Bieler LP (2.81%), State Street Corp (2.63%) and Mackenzie Financial Corp (2.19%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Paul Colvin, Robert Parks, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends
.

How do I buy shares of Syneos Health?

Shares of SYNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $34.66.

How much money does Syneos Health make?

Syneos Health (NASDAQ:SYNH) has a market capitalization of $3.57 billion and generates $5.21 billion in revenue each year. The company earns $234.83 million in net income (profit) each year or $2.75 on an earnings per share basis.

How many employees does Syneos Health have?

The company employs 28,000 workers across the globe.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for the company is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360.

This page (NASDAQ:SYNH) was last updated on 12/6/2022 by MarketBeat.com Staff